Geopolitics Alpha

Hims & Hers Short Interest Hits 23% as Q3 Earnings Test Looms

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

Hims & Hers Short Interest Hits 23% as Q3 Earnings Test Looms

Hims & Hers Health reports third-quarter results Monday with short interest at 23% and the stock down about 65% from its 2025 peak near $72.78.…

Directly affected

  • HIMS Hims & Hers Health-9.7% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Hims & Hers Health belongs to, so it often moves with news about it.

  • HCA HCA Healthcare+14.3% 30d

    HCA Healthcare is a large health company like Hims & Hers Health; big names in a sector often move together.

  • NTRA Natera-24.6% 30d

    Natera is a large health company like Hims & Hers Health; big names in a sector often move together.

  • LH Labcorp Holdings+18.7% 30d

    Labcorp Holdings is a large health company like Hims & Hers Health; big names in a sector often move together.

  • DGX Quest Diagnostics+7.6% 30d

    Quest Diagnostics is a large health company like Hims & Hers Health; big names in a sector often move together.

  • THC Tenet Healthcare+9.9% 30d

    Tenet Healthcare is a large health company like Hims & Hers Health; big names in a sector often move together.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
HIMS-3.00%+2.44%baseafter closeafter closeafter closeafter close
XLV-0.10%+2.63%baseafter closeafter closeafter closeafter close
HCA-5.47%+3.27%baseafter closeafter closeafter closeafter close
NTRA+22.04%+25.98%baseafter closeafter closeafter closeafter close
LH-2.99%+0.31%baseafter closeafter closeafter closeafter close
DGX-1.88%-0.02%baseafter closeafter closeafter closeafter close
THC-5.24%+3.06%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Hims & Hers Short Interest Hits 23% as Q3 Earnings Test Looms BigGo Finance

Source: BigGo Finance

This story

CompanyWhenMoveStatus
DGXthree days earlier-0.02%final price
DGXfive days earlier-1.88%final price
HCAthree days earlier+3.27%final price
HCAfive days earlier-5.47%final price
HIMSthree days earlier+2.44%final price
HIMSfive days earlier-3.00%final price
LHthree days earlier+0.31%final price
LHfive days earlier-2.99%final price
NTRAthree days earlier+25.98%final price
NTRAfive days earlier+22.04%final price
THCthree days earlier+3.06%final price
THCfive days earlier-5.24%final price
XLVthree days earlier+2.63%final price
XLVfive days earlier-0.10%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Hims & Hers Short Interest Hits 23% as Q3 Earnings Test Looms” scores 12 out of 100. The score uses 1 sources.